| A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria ME Patarroyo, R Amador, P Clavijo, A Moreno, F Guzman, P Romero, ... Nature 332 (6160), 158, 1988 | 496 | 1988 |
| Induction of protective immunity against experimental infection with malaria using synthetic peptides ME Patarroyo, P Romero, ML Torres, P Clavijo, A Moreno, A Martínez, ... Nature 328 (6131), 629-632, 1987 | 363 | 1987 |
| Peptide synthesis: chemical or enzymatic F Guzmán, S Barberis, A Illanes Electronic Journal of Biotechnology 10 (2), 279-314, 2007 | 193 | 2007 |
| Google Scholar como herramienta para la evaluación científica. D Torres-Salinas, R Ruiz-Pérez, E Delgado-López-Cózar El profesional de la información 18 (5), 501-510, 2009 | 154 | 2009 |
| Immunization of cattle with synthetic peptides derived from the Boophilus microplus gut protein (Bm86) JH Patarroyo, RW Portela, RO De Castro, JC Pimentel, F Guzman, ... Veterinary immunology and immunopathology 88 (3-4), 163-172, 2002 | 141 | 2002 |
| Identification of Plasmodium falciparum MSP‐1 peptides able to bind to human red blood cells M URQUIZA, LE RODRIGUEZ, JE SUAREZ, F GUZMÁN, M OCAMPO, ... Parasite immunology 18 (10), 515-526, 1996 | 133 | 1996 |
| T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients L Guilherme, SE Oshiro, KC Faé, E Cunha-Neto, G Renesto, AC Goldberg, ... Infection and Immunity 69 (9), 5345-5351, 2001 | 113 | 2001 |
| Antimicrobial peptides: promising compounds against pathogenic microorganisms J Cruz, C Ortiz, F Guzman, R Fernandez-Lafuente, R Torres Current medicinal chemistry 21 (20), 2299-2321, 2014 | 111 | 2014 |
| The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity R Amador, A Moreno, V Valero, L Murillo, AL Mora, M Rojas, C Rocha, ... Vaccine 10 (3), 179-184, 1992 | 109 | 1992 |
| Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21 O Kashala, R Amador, MV Valero, A Moreno, A Barbosa, B Nickel, ... Vaccine 20 (17-18), 2263-2277, 2002 | 98 | 2002 |
| Plasmodium falciparum EBA-175 kDa protein peptides which bind to human red blood cells LE Rodriguez, M Urquiza, M Ocampo, J Suarez, H Curtidor, F Guzman, ... Parasitology 120 (3), 225-235, 2000 | 90 | 2000 |
| Immunodiagnosis of parasitic diseases with synthetic peptides O Noya, ME Patarroyo, F Guzman, BA de Noya Current Protein and Peptide Science 4 (4), 299-308, 2003 | 89 | 2003 |
| Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum R Rodriguez, A Moreno, F Guzman, M Calvo, ME Patarroyo The American journal of tropical medicine and hygiene 43 (4), 339-354, 1990 | 87 | 1990 |
| anad ME Patarroyo. 1990 R Rodriguez, A Moreno, F Guzman, M Calvo Studies in owl monkeys leading to the development of a synthetic vaccine …, 0 | 85 | |
| Structure, immunogenicity, and protectivity relationship for the 1585 malarial peptide and its substitution analogues F Espejo, M Cubillos, LM Salazar, F Guzman, M Urquiza, M Ocampo, ... Angewandte Chemie International Edition 40 (24), 4654-4657, 2001 | 80 | 2001 |
| Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66 JE Rosas, RM Hernandez, AR Gascon, M Igartua, F Guzman, ... Vaccine 19 (31), 4445-4451, 2001 | 75 | 2001 |
| Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial R Amador, A Moreno, LA Murillo, O Sierra, D Saavedra, M Rojas, AL Mora, ... Journal of Infectious Diseases 166 (1), 139-144, 1992 | 75 | 1992 |
| Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres JE Rosas, JL Pedraz, RM Hernandez, AR Gascon, M Igartua, F Guzman, ... Vaccine 20 (13-14), 1707-1710, 2002 | 72 | 2002 |
| Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis M Soto, JM Requena, L Quijada, MJ Perez, CG Nieto, F Guzman, ... Clinical & Experimental Immunology 115 (2), 342-349, 1999 | 68 | 1999 |
| Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia MV Valero, R Amador, JJ Aponte, A Narvaez, C Galindo, Y Silva, J Rosas, ... Vaccine 14 (15), 1466-1470, 1996 | 62 | 1996 |
